As shown in Fig. 3A–B, PD-1, TIGIT, TIM3, and LAG3 expression by MFI was not significantly different between HD and late relapsed multiple myeloma CAR T-cell products. This evidence concerns the gene TIGIT and plasma cell myeloma.